Year |
Citation |
Score |
2014 |
Nurminskaya M, Beazley KE, Smith EP, Belkin AM. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation. Journal of Vascular Research. 51: 418-28. PMID 25612735 DOI: 10.1159/000369461 |
0.481 |
|
2014 |
Beazley KE, Nurminskaya M. BMP2 cross-linked by transglutaminase 2 to collagen-plla scaffold promotes osteogenic differentiation in mesenchymal stem cells. Biotechnology Letters. 36: 1901-7. PMID 24930093 DOI: 10.1007/S10529-014-1551-0 |
0.422 |
|
2014 |
Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K. Transglutaminase regulation of cell function. Physiological Reviews. 94: 383-417. PMID 24692352 DOI: 10.1152/Physrev.00019.2013 |
0.352 |
|
2014 |
Konoplyannikov M, Nurminskaya M. New therapeutic approaches to arterial calcification via inhibition of transglutaminase and β-catenin signaling. Current Pharmaceutical Design. 20: 5811-20. PMID 24533936 DOI: 10.2174/1381612820666140212205059 |
0.461 |
|
2014 |
Nurminskaya M, Beazley K. Wnt16 as a new regulator of vascular calcification Bone Abstracts. DOI: 10.1530/Boneabs.3.Pp384 |
0.321 |
|
2013 |
Beazley KE, Reckard S, Nurminsky D, Lima F, Nurminskaya M. Two sides of MGP null arterial disease chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin Journal of Biological Chemistry. 288: 31400-31408. PMID 24036114 DOI: 10.1074/Jbc.M113.495556 |
0.334 |
|
2013 |
Deasey S, Nurminsky D, Shanmugasundaram S, Lima F, Nurminskaya M. Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling. Cellular Signalling. 25: 2646-51. PMID 23993960 DOI: 10.1016/J.Cellsig.2013.08.016 |
0.766 |
|
2013 |
Niger C, Beazley KE, Nurminskaya M. Induction of chondrogenic differentiation in mesenchymal stem cells by TGF-beta cross-linked to collagen-PLLA [poly(L-lactic acid)] scaffold by transglutaminase 2. Biotechnology Letters. 35: 2193-9. PMID 23892982 DOI: 10.1007/S10529-013-1301-8 |
0.449 |
|
2013 |
Beazley KE, Eghtesad S, Nurminskaya MV. Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein. The Journal of Biological Chemistry. 288: 2632-40. PMID 23223575 DOI: 10.1074/Jbc.M112.368639 |
0.387 |
|
2013 |
Beazley KE, Banyard D, Lima F, Deasey SC, Nurminsky DI, Konoplyannikov M, Nurminskaya MV. Transglutaminase inhibitors attenuate vascular calcification in a preclinical model. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 43-51. PMID 23117658 DOI: 10.1161/Atvbaha.112.300260 |
0.757 |
|
2013 |
Deasey S, Shanmugasundaram S, Nurminskaya M. Tissue-specific responses to loss of transglutaminase 2. Amino Acids. 44: 179-87. PMID 22194042 DOI: 10.1007/S00726-011-1183-9 |
0.726 |
|
2013 |
Deasey S, Nurminsky D, Shanmugasundaram S, Lima F, Nurminskaya M. Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling Cellular Signalling. 25: 2646-2651. DOI: 10.1016/j.cellsig.2013.08.016 |
0.758 |
|
2012 |
Beazley KE, Zhang T, Lima F, Pozharskaya T, Niger C, Tzitzikov E, Azimzadeh AM, Nurminskaya M. Implication for transglutaminase 2-mediated activation of β-catenin signaling in neointimal vascular smooth muscle cells in chronic cardiac allograft rejection. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 31: 1009-17. PMID 22694852 DOI: 10.1016/J.Healun.2012.04.009 |
0.473 |
|
2012 |
Lin X, Shanmugasundaram S, Liu Y, Derrien A, Nurminskaya M, Zamora PO. B2A peptide induces chondrogenic differentiation in vitro and enhances cartilage repair in rats. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 30: 1221-8. PMID 22271086 DOI: 10.1002/Jor.22078 |
0.325 |
|
2012 |
Beazley KE, Deasey S, Lima F, Nurminskaya MV. Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 123-30. PMID 22034513 DOI: 10.1161/Atvbaha.111.237834 |
0.765 |
|
2012 |
Shanmugasundaram S, Logan-Mauney S, Burgos K, Nurminskaya M. Tissue transglutaminase regulates chondrogenesis in mesenchymal stem cells on collagen type XI matrices. Amino Acids. 42: 1045-53. PMID 21830118 DOI: 10.1007/S00726-011-1019-7 |
0.34 |
|
2012 |
Deasey S, Grichenko O, Du S, Nurminskaya M. Characterization of the transglutaminase gene family in zebrafish and in vivo analysis of transglutaminase-dependent bone mineralization. Amino Acids. 42: 1065-75. PMID 21809079 DOI: 10.1007/S00726-011-1021-0 |
0.735 |
|
2012 |
Deasey⁎ S, Nurminskaya M, Du S. Transglutaminase-mediated cross-linking is critical for bone regeneration in zebrafish Bone. 50: S48-S49. DOI: 10.1016/j.bone.2012.02.132 |
0.729 |
|
2011 |
Nurminsky D, Shanmugasundaram S, Deasey S, Michaud C, Allen S, Hendig D, Dastjerdi A, Francis-West P, Nurminskaya M. Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis Mechanisms of Development. 128: 234-245. PMID 21129482 DOI: 10.1016/J.Mod.2010.11.007 |
0.747 |
|
2011 |
Nurminskaya⁎ M, Deasey S, Shanmugasundaram S, Konoplyannikov M. Transglutaminase 2 coordinates bone-cartilage development via pka and b-catenin signaling Bone. 48: S101. DOI: 10.1016/J.Bone.2011.03.153 |
0.743 |
|
2008 |
Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M. Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. Febs Letters. 582: 1552-7. PMID 18405667 DOI: 10.1016/J.Febslet.2008.03.053 |
0.438 |
|
2007 |
Mikhaylova L, Malmquist J, Nurminskaya M. Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcified Tissue International. 81: 372-81. PMID 17982705 DOI: 10.1007/S00223-007-9073-6 |
0.401 |
|
2007 |
Nurminsky D, Magee C, Faverman L, Nurminskaya M. Regulation of chondrocyte differentiation by actin-severing protein adseverin Developmental Biology. 302: 427-437. PMID 17097081 DOI: 10.1016/J.Ydbio.2006.09.052 |
0.4 |
|
2006 |
Nurminskaya M, Kaartinen MT. Transglutaminases in mineralized tissues. Frontiers in Bioscience : a Journal and Virtual Library. 11: 1591-606. PMID 16368540 DOI: 10.2741/1907 |
0.469 |
|
2006 |
Nurminskaya M, Malmquist J. Regulation of transglutaminase-induced calcification in VSM cells by the LRP/beta-catenin Vascular Pharmacology. 45: e109. DOI: 10.1016/J.Vph.2006.08.296 |
0.303 |
|
2003 |
Nurminskaya M, Magee C, Faverman L, Linsenmayer TF. Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Developmental Biology. 263: 139-52. PMID 14568552 DOI: 10.1016/S0012-1606(03)00445-7 |
0.474 |
|
2001 |
Magee C, Nurminskaya M, Linsenmayer TF. UDP-glucose pyrophosphorylase: up-regulation in hypertrophic cartilage and role in hyaluronan synthesis. The Biochemical Journal. 360: 667-74. PMID 11736658 DOI: 10.1042/Bj3600667 |
0.336 |
|
1998 |
Nurminskaya M, Magee C, Nurminsky D, Linsenmayer TF. Plasma transglutaminase in hypertrophic chondrocytes: Expression and cell-specific intracellular activation produce cell death and externalization Journal of Cell Biology. 142: 1135-1144. PMID 9722623 DOI: 10.1083/Jcb.142.4.1135 |
0.344 |
|
1998 |
Linsenmayer TF, Long F, Nurminskaya M, Chen Q, Schmid TM. Type X collagen and other up-regulated components of the avian hypertrophic cartilage program. Progress in Nucleic Acid Research and Molecular Biology. 60: 79-109. PMID 9594572 DOI: 10.1016/S0079-6603(08)60890-9 |
0.339 |
|
1996 |
Nurminskaya M, Linsenmayer TF. Identification and characterization of up-regulated genes during chondrocyte hypertrophy. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 206: 260-71. PMID 8896982 DOI: 10.1002/(Sici)1097-0177(199607)206:3<260::Aid-Aja4>3.0.Co;2-G |
0.325 |
|
Show low-probability matches. |